Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
University of Maryland School of Medicine, Baltimore, USA.
Intravenous immunoglobulin (IVIG) has been used primarily for immune deficiency patients, and its greatest expansion is seen more and more in the treatment of autoimmune disorders, especially in neurology. The benefits of IVIG treatment include its availability in all treatment centers and its ease of administration in an outpatient setting. This article gives an overview of some autoimmune neurologic diseases and explores the clinical evidence supporting the use of IVIG.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on